Posted on August 13, 2018 by Sitemaster
A newly published review by staff of the Center for Devices and Radiological Health (CDRH at the U.S. Food & Drug Administration (FD) addresses the potential role for patient preference information (PPI) in determining patient perceptions of the “value” of high-intensity focused ultrasound (HIFU) and similar techniques in the management of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: approval, benefit, devices, FDA, HIFU, information, medical, patient, preference, risk | Leave a comment »
Posted on December 30, 2015 by Sitemaster
A new study in JAMA Oncology has suggested that surgical orchiectomy may have lower risk for complications and side effects than medical castration with LHRH agonists (also known as GnRH agonists) like leuprolide acetate (Lupron) and others in treatment of men newly diagnosed with metastatic prostate cancer. This is a complex issue! … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: adverse effects, castration, medical, metastatic, orchiectomy, surgical | 11 Comments »
Posted on August 2, 2012 by Sitemaster
When women and their doctors talk about “hormone therapy” they are most commonly referring to the (now) highly controversial issue of whether hormonal supplements (estrogen and progesterone) should be used at and after menopause to prevent the symptoms of menopause and/or later risks related to heart disease and osteoporesis. … READ MORE …
Filed under: Management, Treatment | Tagged: androgen deprivation, castration, definition, hormone therapy, medical, surgical | 21 Comments »
Posted on August 2, 2010 by Sitemaster
A story in the Boston Globe this morning documents two cases in which prostate biopsy results given to a specific patient were inaccurate because the wrong patient data was provided by a pathology laboratory. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: error, laboratory, medical | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 